Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Income from Continuing Operations (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Income from Continuing Operations data on record, last reported at 17428000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 150.96% year-over-year to 17428000.0; the TTM value through Dec 2025 reached 72729000.0, changed N/A, while the annual FY2025 figure was 72729000.0, N/A changed from the prior year.
  • Income from Continuing Operations reached 17428000.0 in Q4 2025 per PLSE's latest filing, up from 19338000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 34200000.0 in Q4 2024 and bottomed at 19338000.0 in Q3 2025.
  • Average Income from Continuing Operations over 5 years is 11886750.0, with a median of 14139000.0 recorded in 2021.
  • Peak YoY movement for Income from Continuing Operations: skyrocketed 386.6% in 2024, then plummeted 150.96% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 15416000.0 in 2021, then surged by 40.34% to 9197000.0 in 2022, then dropped by 29.75% to 11933000.0 in 2023, then skyrocketed by 386.6% to 34200000.0 in 2024, then tumbled by 150.96% to 17428000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 17428000.0 in Q4 2025, 19338000.0 in Q3 2025, and 19168000.0 in Q2 2025.